Drug recall
Zyprexa Tablets (Olanzapine), 10 mg., 60-tablet bottles, Rx only, NDC 0002-4117-60, Eli Lilly and Company…
FDA recall event 27157 · Class II · D & K Healthcare Resources, Inc.
Key facts
| Event ID | 27157 |
|---|---|
| Recall numbers | D-338-3, D-339-3, D-340-3, D-341-3 |
| Recalling firm | D & K Healthcare Resources, Inc. |
| Product type | Drugs |
| Products | Zyprexa Tablets (Olanzapine), 10 mg., 60-tablet bottles, Rx only, NDC 0002-4117-60, Eli Lilly and Company, Indianapolis, IN. 46825, USA, Zyprexa Tablets (Olanzapine), 15 mg., 60-tablet bottles, Rx only, NDC-0002-4115-60, Eli Lilly and Company, Indianapolis, IN. 46285, USA, Zyprexa Tablets (Olanzapine) 20 mg., 60-tablet bottles, Rx only, Eli Lilly and Company, Indianapolis, IN. 46285, USA, Zyprexa Tablets (Olanzapine), 5 mg., 60-tablet bottles, Rx only, Eli Lilly and Company, Indianapolis, IN. 46285, USA |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Counterfeit : An unknown number of bottles bearing these lot numbers are counterfeit, in that they have been repackaged, relabeled and/or may contain different strengths or mixed strength tablets… |
| Initiation date | Aug 25, 2003 |
| City | Saint Louis |
| Country | United States |
| FEI number | 3004129686 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports